Indefinite Delivery Contract 75D30126D20714
Award Date 12/31/25
Last Date to Order 2/28/27
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The Centers for Disease Control and Prevention awarded a single-award indefinite delivery contract to Glaxosmithkline, LLC to procure adult influenza vaccines. The contract has a potential value of $13 million and a period of performance from December 2020 through February 2022. The original solicitation sought proposals for the purchase of influenza vaccines for individuals aged 19 years and older to support immunization programs under Section 317(j) of the Public Health Service Act. Offerors...
- The Indefinite Delivery Contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh provides adult flu vaccines for the 2023-2024 period. Glaxosmithkline, LLC was awarded a multiple award contract with a potential value of $13.9 million to deliver flu vaccines through February 2028 under associated task orders or price lists. The solicitation aimed to procure adult flu vaccines to support the Centers for Disease Control and Prevention's...
- The Centers for Disease Control and Prevention awarded an indefinite delivery contract to Glaxosmithkline, LLC for adult influenza vaccines. The contract has a potential value of $13.41 million to supply a minimum of 100 doses and maximum of 20 million doses of inactivated influenza vaccine for individuals aged 19 years and older through February 28, 2023. Vaccines must be licensed by the FDA and manufactured in compliance with cGMP regulations. Delivery locations include CDC distribution...
- This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company, to provide adult influenza vaccines for the 2024-2025 season. The $13,916,000 multiple award IDC has a period of performance through February 28, 2025. The contract does not have any set-aside designations. Glaxosmithkline will likely provide the vaccines from its facilities in North Carolina to support the CDC's immunization programs...
- The Centers for Disease Control and Prevention (CDC) awarded a single award Indefinite Delivery Contract to Glaxosmithkline, LLC, a pharmaceutical company, to procure pediatric influenza vaccines for the 2022-2023 season. The contract has a potential value of $168,590,000 and a period of performance from the date of award through February 28, 2023. The original solicitation sought between 100 doses and 50 million doses of pediatric influenza vaccine to be delivered to CDC distribution centers in...
- This indefinite-delivery, indefinite-quantity (IDIQ) contract was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases, to Glaxosmithkline, LLC, a pharmaceutical company, for the purchase of 12 standard adult vaccines. The $172.4 million contract has a one-year period of performance from July 1, 2022 to June 30, 2023 and does not utilize any set-asides. The vaccines, which include influenza, hepatitis, pneumococcal, and...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to the pharmaceutical company Glaxosmithkline, LLC to provide pediatric influenza vaccines for the 2024-2025 timeframe. The contract has a ceiling value of $182,592,000 and a period of performance through February 28, 2025. Glaxosmithkline, a foreign-owned for-profit organization, has extensive experience as a prime contractor providing a range of pharmaceutical products and services to...
- This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to GlaxoSmithKline Holdings (Americas) Inc. The single-award contract has a ceiling value of $11,968,367.50 and a period of performance from March 15, 2010 to February 28, 2011. The contract aims to procure influenza vaccine services for the CDC's Vaccine for Children (VFC) program in 2010. The VFC program provides vaccines at no cost to...
- This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency, to GlaxoSmithKline Holdings (Americas) Inc. The contract has a ceiling value of $20,661,104.25 and a period of performance from March 15, 2010 to February 28, 2011. The contract appears to be for the procurement of flu vaccine products and related services as part of the CDC's Vaccine for Children (VFC) program. While the exact scope...
- The Centers for Disease Control and Prevention (CDC) Pittsburgh awarded a multiple-award Indefinite Delivery Contract to GlaxoSmithKline, LLC (UEI: FRHTPHMZMX47) with a ceiling value of $103.0 million for the procurement of adult vaccines. The contract was awarded on July 1, 2025, with an ultimate completion date of June 30, 2026, and carries no small business set-aside designation. As the prime contractor, GlaxoSmithKline will supply vaccines and related pharmaceutical products to support the...